Science Market Update

UMass Researcher Granted $2.3M to Study Tuberculosis

Posted by Laura Braden on Fri, Nov 03, 2017

Life science researchers learn about new lab supplies at a past UMass BioResearch Product Faire Event.Tuberculosis (TB) is an infectious disease that affects nearly 1/3 of the world's population. Although eradication efforts have been undertaken, none have been successful and TB is still a leading cause around the world. Even though there are treatment methods for this infection, they are not always successful at killing the bacteria that cause TB. This provides life science researchers with more questions and research topics, to better understand the infection and bacteria and what causes treatments to work occasionally, but not always

Read More

Tags: tuberculosis, University of Massachusetts Amherst, new research funding, MA, NIH funding, Amherst, UMASS, 2018, TB Research

Portland Scientists Awarded $3M for Tuberculosis Vaccine Research

Posted by Laura Braden on Mon, Feb 01, 2016

Oregon Health and Science University has received $3 million for tuberculosis treatment research.

Tuberculosis is the number one cause of death by infectious disease around the world. In 2014, this contagious bacterial infection was responsible for 1.5 million deaths worldwide. Although the disease is treatable and curable, it still persists as a global health problem that scientists continue to study, to develop new and improved treatments. 

The Bill & Melinda Gates Foundation recently granted scientists from the Oregon Health and Science University $3 million to research potential vaccines for tuberculosis

Read More

Tags: The Bill and Melinda Gates Foundation, tuberculosis, Oregon Health and Science University, Northwest, OR, OHSU, Portland, new funding, 2016, BioResearch Product Faire, MAIT cells

UAB Scientists Uncover TNT in Fight Against TB

Posted by Robert Larkin on Mon, Oct 12, 2015

exposives-cart-1206433-1Tuberculosis is a terrible disease that is characterized by a bad, sometimes bloody cough, and which could lead to other serious health problems, or even death.

Over 1.5 million people currently die from TB each year, and as many as one third of the world’s population is currently infected, according to the Centers for Disease Control and Prevention.

In an effort to combat this worldwide health concern, Michael Niederweis, Ph.D., and colleagues from the University of Alabama at Birmingham have made an important discovery. The scientists recently uncovered an important toxin called Tuberculosis Necrotizing Toxin (TNT) that resides within the pathogenic bacterium Mycobacterium tuberculosis and aids in survival and proliferation.

Read More

Tags: tuberculosis, Immunology, Alabama, Biology, 2015, disease research, life science research, UAlab, Birmingham, AL, Southern Region, University of Alabama at Birmingham, BioResearch Product Faire™

Biochemicals From the Deep Target Tuberculosis

Posted by Sam Asher on Thu, Apr 04, 2013

When it comes to developing drugs for disease prevention and treatment, sometimes it is best not to reinvent the wheel- especially when nature holds so many solutions to those enterprising (or fortunate) individuals who know where to look.  One such researcher, Professor Brian Murphy of the University of Illinois, Chicago, collects hundreds of possibly curative species of bacteria from one of nature’s least explored resources: the floors of lakes and oceans.

Read More

Tags: 2014, Midwest, 2013, University of Illinois, tuberculosis, biochemicals, BioResearch Product Faire Event, Chicago, IL, UIChgo, actinomycete

Subscribe to Company News